• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

流行性腮腺炎病毒感染的现状:流行病学、发病机制和疫苗。

Current Status of Mumps Virus Infection: Epidemiology, Pathogenesis, and Vaccine.

机构信息

Department of Occupational Medicine, Chi-Mei Medical Center, Tainan, 710, Taiwan.

Department of Surveillance, Centers for Disease Control, Taipei, 100, Taiwan.

出版信息

Int J Environ Res Public Health. 2020 Mar 5;17(5):1686. doi: 10.3390/ijerph17051686.

DOI:10.3390/ijerph17051686
PMID:32150969
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7084951/
Abstract

Mumps is an important childhood infectious disease caused by mumps virus (MuV). We reviewed the epidemiology, pathogenesis, and vaccine development of mumps. Previous studies were identified using the key words "mumps" and "epidemiology", "pathogenesis" or "vaccine" in MEDLINE, PubMed, Embase, Web of Science, and Google Scholar. We excluded the articles that were not published in the English language, manuscripts without abstracts, and opinion articles from the review. The number of cases caused by MuV decreased steeply after the introduction of the mumps vaccine worldwide. In recent years, a global resurgence of mumps cases in developed countries and cases of aseptic meningitis caused by some mumps vaccine strains have renewed the importance of MuV infection worldwide. The performance of mumps vaccination has become an important issue for controlling mumps infections. Vaccine development and routine vaccination are still effective measures to globally reduce the incidence of mumps infections. During outbreaks, a third of MMR vaccine is recommended for groups of persons determined by public authorities.

摘要

流行性腮腺炎是由腮腺炎病毒(MuV)引起的一种重要的儿童传染病。我们综述了流行性腮腺炎的流行病学、发病机制和疫苗开发。使用 MEDLINE、PubMed、Embase、Web of Science 和 Google Scholar 中的关键词“流行性腮腺炎”和“流行病学”、“发病机制”或“疫苗”来确定先前的研究。我们排除了非英文发表的文章、无摘要的手稿和观点文章。全球引入腮腺炎疫苗后,由 MuV 引起的病例数量急剧下降。近年来,发达国家流行性腮腺炎病例的全球再现以及某些腮腺炎疫苗株引起的无菌性脑膜炎病例,使 MuV 感染在全球范围内再次受到重视。腮腺炎疫苗接种的效果成为控制腮腺炎感染的重要问题。疫苗开发和常规疫苗接种仍然是全球减少腮腺炎感染发病率的有效措施。在暴发期间,建议由公共当局确定的人群接种三分之一的麻疹、腮腺炎和风疹联合疫苗。

相似文献

1
Current Status of Mumps Virus Infection: Epidemiology, Pathogenesis, and Vaccine.流行性腮腺炎病毒感染的现状:流行病学、发病机制和疫苗。
Int J Environ Res Public Health. 2020 Mar 5;17(5):1686. doi: 10.3390/ijerph17051686.
2
Outbreak of aseptic meningitis associated with mass vaccination with a urabe-containing measles-mumps-rubella vaccine: implications for immunization programs.与含尿疹的麻疹-腮腺炎-风疹疫苗大规模接种相关的无菌性脑膜炎暴发:对免疫规划的影响
Am J Epidemiol. 2000 Mar 1;151(5):524-30. doi: 10.1093/oxfordjournals.aje.a010239.
3
Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain.使用列宁格勒-萨格勒布腮腺炎毒株的麻疹-腮腺炎-风疹(MMR)疫苗大规模接种后发生无菌性脑膜炎和腮腺炎疫情。
Vaccine. 2002 Jan 15;20(7-8):1106-12. doi: 10.1016/s0264-410x(01)00438-8.
4
The risk of aseptic meningitis associated with the Leningrad-Zagreb mumps vaccine strain following mass vaccination with measles-mumps-rubella vaccine, Rio Grande do Sul, Brazil, 1997.1997年,巴西南里奥格兰德州大规模接种麻疹-腮腺炎-风疹疫苗后,与列宁格勒-萨格勒布腮腺炎疫苗株相关的无菌性脑膜炎风险。
Int J Epidemiol. 2002 Oct;31(5):978-82. doi: 10.1093/ije/31.5.978.
5
An outbreak of mumps in the metropolitan area of Walsall, UK.英国沃尔索尔都会区爆发腮腺炎疫情。
Int J Infect Dis. 2002 Dec;6(4):283-7. doi: 10.1016/s1201-9712(02)90162-1.
6
Molecular biology, pathogenesis and pathology of mumps virus.腮腺炎病毒的分子生物学、发病机制与病理学
J Pathol. 2015 Jan;235(2):242-52. doi: 10.1002/path.4445.
7
Vaccines for measles, mumps and rubella in children.儿童麻疹、腮腺炎和风疹疫苗。
Cochrane Database Syst Rev. 2005 Oct 19(4):CD004407. doi: 10.1002/14651858.CD004407.pub2.
8
A prefecture-wide survey of mumps meningitis associated with measles, mumps and rubella vaccine.一项关于与麻疹、腮腺炎和风疹疫苗相关的腮腺炎脑膜炎的全州范围调查。
Pediatr Infect Dis J. 1991 Mar;10(3):204-9. doi: 10.1097/00006454-199103000-00007.
9
Mumps: an Update on Outbreaks, Vaccine Efficacy, and Genomic Diversity.流行性腮腺炎:暴发、疫苗效力和基因组多样性的最新研究进展
Clin Microbiol Rev. 2020 Feb 26;33(2). doi: 10.1128/CMR.00151-19. Print 2020 Mar 18.
10
A protracted mumps outbreak in Western Australia despite high vaccine coverage: a population-based surveillance study.尽管疫苗接种率很高,但西澳大利亚仍持续爆发腮腺炎:一项基于人群的监测研究。
Lancet Infect Dis. 2019 Feb;19(2):177-184. doi: 10.1016/S1473-3099(18)30498-5. Epub 2018 Dec 14.

引用本文的文献

1
Bibliometric Analysis of Global Scientific Literature on Mumps Vaccines.全球腮腺炎疫苗科学文献的文献计量分析
Cureus. 2025 Jul 29;17(7):e88976. doi: 10.7759/cureus.88976. eCollection 2025 Jul.
2
Development and Biological Properties of a New Live Attenuated Mumps Vaccine Strain.一种新型减毒活腮腺炎疫苗株的研发及生物学特性
Vaccines (Basel). 2025 Aug 20;13(8):879. doi: 10.3390/vaccines13080879.
3
Risk factors for mumps in children under 15 years of age during the transition from single-dose to two-dose MMR vaccination strategy: a matched case-control study.

本文引用的文献

1
Epidemiological Characteristics and Spatiotemporal Analysis of Mumps from 2004 to 2018 in Chongqing, China.中国重庆 2004 年至 2018 年流行性腮腺炎的流行病学特征及时空分析。
Int J Environ Res Public Health. 2019 Aug 22;16(17):3052. doi: 10.3390/ijerph16173052.
2
CDC Guidance for Use of a Third Dose of MMR Vaccine During Mumps Outbreaks.美国疾病控制与预防中心关于在腮腺炎疫情期间使用第三剂麻腮风疫苗的指导意见。
J Public Health Manag Pract. 2020 Mar/Apr;26(2):109-115. doi: 10.1097/PHH.0000000000000962.
3
Immunogenicity and safety of the new MMR vaccine containing measles AIK-C, rubella Takahashi, and mumps RIT4385 strains in Japanese children: a randomized phase I/II clinical trial.
在从单剂量麻疹-腮腺炎-风疹(MMR)疫苗接种策略过渡到双剂量接种策略期间15岁以下儿童患腮腺炎的危险因素:一项配对病例对照研究
Front Public Health. 2025 Jul 7;13:1592602. doi: 10.3389/fpubh.2025.1592602. eCollection 2025.
4
Herd Immunity to the Measles, Mumps and Rubella Viruses Among the Belgradian Population in May, 2024.2024年5月贝尔格莱德人群对麻疹、腮腺炎和风疹病毒的群体免疫
Vaccines (Basel). 2025 Jun 18;13(6):652. doi: 10.3390/vaccines13060652.
5
Collective Immunity to the Measles, Mumps, and Rubella Viruses in the Kyrgyz Population.吉尔吉斯斯坦人群对麻疹、腮腺炎和风疹病毒的群体免疫
Vaccines (Basel). 2025 Feb 27;13(3):249. doi: 10.3390/vaccines13030249.
6
Erythema Multiforme Secondary to Mumps.腮腺炎继发多形红斑
Am J Trop Med Hyg. 2025 Feb 4;112(4):918-920. doi: 10.4269/ajtmh.24-0688. Print 2025 Apr 2.
7
Epidemiological Characteristics of Mumps Cases in the Kingdom of Bahrain From 2012 to 2022.2012年至2022年巴林王国腮腺炎病例的流行病学特征
Cureus. 2024 Dec 29;16(12):e76551. doi: 10.7759/cureus.76551. eCollection 2024 Dec.
8
Structure-based design of glycoprotein subunit vaccines for mumps.基于结构的腮腺炎糖蛋白亚单位疫苗设计。
Proc Natl Acad Sci U S A. 2024 Nov 19;121(47):e2404053121. doi: 10.1073/pnas.2404053121. Epub 2024 Nov 11.
9
Epidemiological characteristics and interrupted time series analysis of mumps in Quzhou City, 2005-2023.2005-2023 年衢州市流行性腮腺炎的流行病学特征及中断时间序列分析。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2411828. doi: 10.1080/21645515.2024.2411828. Epub 2024 Oct 17.
10
Serologic Cross-Reactivity between the Mumps Virus Vaccine Genotype A Strain and the Circulating Genotype G Strain.腮腺炎病毒疫苗 A 基因型株与流行的 G 基因型株之间的血清学交叉反应性。
Viruses. 2024 Sep 8;16(9):1434. doi: 10.3390/v16091434.
新型麻疹 AIK-C、风疹 Takahashi 和腮腺炎 RIT4385 株 MMR 疫苗在日本儿童中的免疫原性和安全性:一项随机 I/II 期临床试验。
Hum Vaccin Immunother. 2019;15(5):1139-1144. doi: 10.1080/21645515.2019.1578591. Epub 2019 Apr 22.
4
Mumps in a highly vaccinated Marshallese community in Arkansas, USA: an outbreak report.美国阿肯色州高度接种疫苗的马绍尔人群中的腮腺炎:暴发报告。
Lancet Infect Dis. 2019 Feb;19(2):185-192. doi: 10.1016/S1473-3099(18)30607-8. Epub 2019 Jan 8.
5
A protracted mumps outbreak in Western Australia despite high vaccine coverage: a population-based surveillance study.尽管疫苗接种率很高,但西澳大利亚仍持续爆发腮腺炎:一项基于人群的监测研究。
Lancet Infect Dis. 2019 Feb;19(2):177-184. doi: 10.1016/S1473-3099(18)30498-5. Epub 2018 Dec 14.
6
Resurgence risk for measles, mumps and rubella in France in 2018 and 2020.2018 年和 2020 年法国麻疹、腮腺炎和风疹的再现风险。
Euro Surveill. 2018 Jun;23(25). doi: 10.2807/1560-7917.ES.2018.23.25.1700796.
7
A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.一项 III 期、开放性标签、随机多中心研究,旨在评估在英国 3 至 4 岁健康儿童中,同时接种麻疹-腮腺炎-风疹疫苗时,两种不同低剂量抗原白喉-破伤风-无细胞百日咳-脊髓灰质炎疫苗加强剂量的免疫原性和安全性。
Vaccine. 2018 Apr 19;36(17):2300-2306. doi: 10.1016/j.vaccine.2018.03.021. Epub 2018 Mar 22.
8
Vaccine waning and mumps re-emergence in the United States.疫苗效力减弱与美国流行性腮腺炎再现
Sci Transl Med. 2018 Mar 21;10(433). doi: 10.1126/scitranslmed.aao5945.
9
Impact of a vaccination programme in children vaccinated with ProQuad, and ProQuad-specific effectiveness against varicella in the Veneto region of Italy.意大利威尼托地区接种百白破-无细胞型百日咳-脊髓灰质炎和 Hib 联合疫苗(ProQuad)儿童的疫苗接种计划的影响和 ProQuad 对水痘的特定效果。
BMC Infect Dis. 2018 Mar 5;18(1):103. doi: 10.1186/s12879-018-3017-9.
10
Mumps: An Emergency Medicine-Focused Update.流行性腮腺炎:以急诊医学为重点的最新进展
J Emerg Med. 2018 Feb;54(2):207-214. doi: 10.1016/j.jemermed.2017.08.037. Epub 2017 Oct 27.